Standing Desks May Not Be The Silver Bullet We Thought

You might want to sit down for this.

Health & Lifestyle
197

Listen to article (english)

Translate to Spanish or other 102 languages!

Standing more doesn’t improve heart health compared to sitting, and after as little as 2 hours, it might actually harm you. Image for illustration purposes
Standing more doesn’t improve heart health compared to sitting, and after as little as 2 hours, it might actually harm you. Image for illustration purposes

Medical News Today

- Advertisement -

If you, like me, have invested in a standing desk, new research from the University of Sydney may challenge an established idea about workplace wellness. After analyzing data from 83,000 adults, researchers uncovered something surprising: Standing more doesn’t improve heart health compared to sitting, and after as little as 2 hours, it might actually harm you.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/can-standing-too-much-harmful-heart-health-sitting?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=sundaysupplement&utm_content=2024-10-27&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
New Stroke Prevention Guidelines Highlight Lifestyle Changes
Next article
A Journey into Ultrasound Technology

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The Silent Toll of Substance Use on Today’s Young Adults

Mega Doctor News by University of Michigan Newswise - Young adults who heavily use substances...
- Advertisement -